ArticleWorld journal of hepatology2022

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma.

Kazuto Tajiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.